Loading video...

Video Failed to Load

Go Home

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the...

rxmeds_store's profile picture

RXMEDS.STORE

3,337 subscribers

16,612 views • 4 months ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure
3:28

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,939 views • 4 months ago

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom
1:37

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom

McCullough Foundation

195,757 views • 5 months ago

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,995 views • 2 months ago

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.
0:59

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 views • 4 months ago

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.
5:23

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,524 views • 3 months ago

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 views • 1 year ago

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 views • 3 months ago

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD
4:13

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

TheSkyMeds | Cancer & Parasites Explained

5,144,279 views • 1 year ago

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,308 views • 3 months ago

🚨 This is so interesting.... look at the cost... and the mechanism. Standard Chemo - $111,000 annually And (according to Gemini) it’s also “generally ineffective at targeting stem cells”. Now listen to Dr. John Campbell covering a recent paper: “Ivermectin and Mebendazole selectively target cancer stem cells”.... interesting? Dr. John Campbell: “The fact that Pharmaceutical companies are making so much money out of this... may have nothing to do with the fact they don’t conduct the clinical trials into Ivermectin....” Mebendazole, Fenbendazole and Ivermectin are still emerging, unproven repurposed drugs under research... but it’s hard to ignore the striking contrast.
2:16

🚨 This is so interesting.... look at the cost... and the mechanism. Standard Chemo - $111,000 annually And (according to Gemini) it’s also “generally ineffective at targeting stem cells”. Now listen to Dr. John Campbell covering a recent paper: “Ivermectin and Mebendazole selectively target cancer stem cells”.... interesting? Dr. John Campbell: “The fact that Pharmaceutical companies are making so much money out of this... may have nothing to do with the fact they don’t conduct the clinical trials into Ivermectin....” Mebendazole, Fenbendazole and Ivermectin are still emerging, unproven repurposed drugs under research... but it’s hard to ignore the striking contrast.

Humanspective

27,254 views • 5 months ago

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells
2:06

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

12,063 views • 2 months ago

THE TRIPLE-ATTACK CANCER PROTOCOL EXPOSED ALEX JONES: Everyone thinks Ivermectin, Fenbendazole, and Mebendazole are identical. You’ve treated 6,000+ Stage 4 patients—why combine all three? DR. WILLIAM MAKIS: Cancer isn’t a single tumor—it’s a fortress. One drug won't do it. You have to cut the fuel, jam communications, and kill the root stem cells simultaneously. THE BIOLOGICAL MECHANISM BREAKDOWN IVERMECTIN: THE STEM CELL DESTROYER • Identifies & kills cancer stem cells (the root cause of recurrence) • Reverses chemotherapy resistance at the molecular level • Selectively targets malignant cells while leaving healthy tissue 100% untouched FENBENDAZOLE: THE ENERGY STARVER • Blocks glucose uptake—literally starving aggressive tumors of fuel • Destroys the internal skeleton of cancer cells so they can't divide • Triggers rapid cell suicide (apoptosis) in fast-growing lesions MEBENDAZOLE: THE BRAIN BARRIER PENETRATOR • Delivers high-impact microtubule destruction • CROSSES THE BLOOD-BRAIN BARRIER (crucial for brain tumors & brain metastases) • Backed by decades of human safety data THE $2.2 BILLION SUPPRESSION PLOT ALEX JONES: 400+ published studies prove these generic compounds work. Why did the media label them "horse paste"? DR. WILLIAM MAKIS: Cartel economics. A $3 generic pill ruins a trillion-dollar cancer industry. • The Patent Grab: In 2021, Johns Hopkins quietly patented Mebendazole for cancer to lock down rights. • The Pharmacy Payoff: Over $2.2 BILLION went to CVS and Walgreens to block doctors from filling generic off-label prescriptions. • The Trap: Forces patients onto multi-million dollar chemo stacks that fail against stem cells. ALEX JONES: What are the scans showing? DR. WILLIAM MAKIS: • Complete tumor resolution in aggressive "turbo cancers" after chemo failed. • CEA tumor markers dropping from 100,000+ down to normal levels. • The world's first peer-reviewed protocol for dosing Ivermectin & Fenbendazole is now officially published. When $3 generics systematically beat multi-million dollar protocols, the narrative collapses. 📌 BOOKMARK THIS THREAD. SAVE A LIFE.
15:09

THE TRIPLE-ATTACK CANCER PROTOCOL EXPOSED ALEX JONES: Everyone thinks Ivermectin, Fenbendazole, and Mebendazole are identical. You’ve treated 6,000+ Stage 4 patients—why combine all three? DR. WILLIAM MAKIS: Cancer isn’t a single tumor—it’s a fortress. One drug won't do it. You have to cut the fuel, jam communications, and kill the root stem cells simultaneously. THE BIOLOGICAL MECHANISM BREAKDOWN IVERMECTIN: THE STEM CELL DESTROYER • Identifies & kills cancer stem cells (the root cause of recurrence) • Reverses chemotherapy resistance at the molecular level • Selectively targets malignant cells while leaving healthy tissue 100% untouched FENBENDAZOLE: THE ENERGY STARVER • Blocks glucose uptake—literally starving aggressive tumors of fuel • Destroys the internal skeleton of cancer cells so they can't divide • Triggers rapid cell suicide (apoptosis) in fast-growing lesions MEBENDAZOLE: THE BRAIN BARRIER PENETRATOR • Delivers high-impact microtubule destruction • CROSSES THE BLOOD-BRAIN BARRIER (crucial for brain tumors & brain metastases) • Backed by decades of human safety data THE $2.2 BILLION SUPPRESSION PLOT ALEX JONES: 400+ published studies prove these generic compounds work. Why did the media label them "horse paste"? DR. WILLIAM MAKIS: Cartel economics. A $3 generic pill ruins a trillion-dollar cancer industry. • The Patent Grab: In 2021, Johns Hopkins quietly patented Mebendazole for cancer to lock down rights. • The Pharmacy Payoff: Over $2.2 BILLION went to CVS and Walgreens to block doctors from filling generic off-label prescriptions. • The Trap: Forces patients onto multi-million dollar chemo stacks that fail against stem cells. ALEX JONES: What are the scans showing? DR. WILLIAM MAKIS: • Complete tumor resolution in aggressive "turbo cancers" after chemo failed. • CEA tumor markers dropping from 100,000+ down to normal levels. • The world's first peer-reviewed protocol for dosing Ivermectin & Fenbendazole is now officially published. When $3 generics systematically beat multi-million dollar protocols, the narrative collapses. 📌 BOOKMARK THIS THREAD. SAVE A LIFE.

GenericRxOnline.com

40,966 views • 1 month ago

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 views • 2 years ago

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance
6:30

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

Jan Jekielek

96,002 views • 1 year ago

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."
4:27

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."

Sense Receptor

96,616 views • 10 months ago

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom
0:54

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

16,051 views • 5 months ago

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness
8:54

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness

skymeds store | Online Ivermectin Pharmacy

3,350,823 views • 1 year ago

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch
4:26

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch

RXMEDS.STORE

27,610 views • 18 days ago

Dr. Thomas Seyfried reveals why parasite drugs like fenbendazole & mebendazole crush cancer cells: They target the exact same energy pathway that cancer cells hijack — fermentation of glucose and glutamine — the same pathway many parasites use once settled in tissue. Short science nugget: Fenbendazole and mebendazole disrupt microtubule formation and block glucose/glutamine uptake, starving cancer cells of their primary fuels while sparing healthy cells that rely more on oxidative phosphorylation (peer-reviewed in vitro & animal studies, e.g., Dogra et al. 2018, Zhang et al. 2021, and Seyfried lab publications) Key points from Seyfried: - Structurally almost identical → likely equally effective - Cancer is not a parasite, but it metabolizes like one - These drugs don’t care — they hit the shared vulnerability Cocktails of them may work even better. Is this the overlooked cancer weapon big pharma ignores? Have you or someone you know explored benzimidazoles like fenbendazole/mebendazole?
2:11

Dr. Thomas Seyfried reveals why parasite drugs like fenbendazole & mebendazole crush cancer cells: They target the exact same energy pathway that cancer cells hijack — fermentation of glucose and glutamine — the same pathway many parasites use once settled in tissue. Short science nugget: Fenbendazole and mebendazole disrupt microtubule formation and block glucose/glutamine uptake, starving cancer cells of their primary fuels while sparing healthy cells that rely more on oxidative phosphorylation (peer-reviewed in vitro & animal studies, e.g., Dogra et al. 2018, Zhang et al. 2021, and Seyfried lab publications) Key points from Seyfried: - Structurally almost identical → likely equally effective - Cancer is not a parasite, but it metabolizes like one - These drugs don’t care — they hit the shared vulnerability Cocktails of them may work even better. Is this the overlooked cancer weapon big pharma ignores? Have you or someone you know explored benzimidazoles like fenbendazole/mebendazole?

Camus

88,327 views • 7 months ago

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.
3:35

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

PharmacyinUSA

14,784 views • 3 months ago